Chesapeake Wealth Management Gilead Sciences, Inc. Transaction History

Chesapeake Wealth Management

$275 Million
Q2 2024

A detailed history of Chesapeake Wealth Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Chesapeake Wealth Management holds 4,666 shares of GILD stock, worth $395,396. This represents 0.12% of its overall portfolio holdings.

Number of Shares

4,666

Previous 4,704 0.81%

Holding current value

$395,396

Previous $344,000 6.98%

% of portfolio

0.12%

Previous 0.13%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $2,399 - $2,769	-38 Reduced 0.81%	4,666 $320,000
Q1 2024 May 07, 2024	BUY	$71.58 - $87.29 $2,720 - $3,317	38 Added 0.81%	4,704 $344,000
Q3 2023 Nov 16, 2023	SELL	$73.94 - $80.67 $6,654 - $7,260	-90 Reduced 1.89%	4,666 $349,000
Q1 2023 Apr 25, 2023	SELL	$77.31 - $88.08 $3,169 - $3,611	-41 Reduced 0.85%	4,756 $394,000
Q1 2022 Apr 19, 2022	SELL	$57.92 - $72.58 $7,066 - $8,854	-122 Reduced 2.48%	4,797 $285,000
Q4 2021 Feb 03, 2022	BUY	$64.88 - $73.64 $16,414 - $18,630	253 Added 5.42%	4,919 $357,000
Q1 2021 Apr 26, 2021	SELL	$60.0 - $68.46 $20,160 - $23,002	-336 Reduced 6.72%	4,666 $302,000
Q1 2020 Apr 29, 2020	SELL	$62.63 - $80.22 $6,263 - $8,022	-100 Reduced 1.96%	5,002 $374,000
Q4 2019 Jan 29, 2020	SELL	$61.62 - $67.78 $21,567 - $23,723	-350 Reduced 6.42%	5,102 $332,000
Q3 2019 Oct 25, 2019	SELL	$62.51 - $69.0 $7,126 - $7,866	-114 Reduced 2.05%	5,452 $346,000
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $50,733 - $56,891	-820 Reduced 12.84%	5,566 $376,000
Q1 2019 Apr 17, 2019	SELL	$62.53 - $70.05 $9,379 - $10,507	-150 Reduced 2.29%	6,386 $415,000
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $22,702 - $29,625	-375 Reduced 5.43%	6,536 $409,000
Q2 2018 Aug 07, 2018	SELL	$64.88 - $75.68 $10,380 - $12,108	-160 Reduced 2.26%	6,911 $490,000
Q1 2018 Jun 04, 2018	BUY	$72.84 - $88.8 $515,051 - $627,904	7,071 New	7,071 $534,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Wealth Management with notifications on news.

Account

Chesapeake Wealth Management Gilead Sciences, Inc. Transaction History